Skip to content
MedsAcross

Brand family

Tavalisse

Fostamatinib · Rigel Pharmaceuticals
United States
Presentations
2
Markets
1

Tavalisse is a brand of Fostamatinib marketed by Rigel Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Fostamatinib
Brand owner
Rigel Pharmaceuticals
Registered in
United States
Strengths and forms
100 mg tablet, 150 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Tavalisse 100 mg tabletOralRigel PharmaceuticalsUS FDAAvailable on request
Tavalisse 150 mg tabletOralRigel PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Tavalisse

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.